Global Active Pharmaceutical Ingredients Market Overview to 2026

0

DUBLIN, January 20, 2022 /PRNewswire/ — The “Global Active Pharmaceutical Ingredients (APIs) Market – Analysis by Drug Type (Generic, Innovative), Synthesis (Synthetic, Biotech), by Application, by Region, by Country (2021 Edition): Overview of Market and Forecast with the Impact of COVID-19 (2021-2026)” has been added to from ResearchAndMarkets.com offer.

Research and Markets Logo

According to this report, the global active pharmaceutical ingredients market is expected to exhibit robust growth represented by a CAGR of 6.96% during the period 2021-2026.

The Global Active Pharmaceutical Ingredients Market has been valued at $179.6 billion in 2020. The growth opportunities for the Active Pharmaceutical Ingredients market are attributed to growing geriatric population, rising technical advancements, increasing API manufacturing facilities globally, and growing number of research and development activities by some of the leading market players in the global platform.

Rising awareness as well as investment in new drug development in the market is increasing the number of clinical trials globally, driving up the active pharmaceutical ingredient market. With the increasing prevalence of respiratory diseases due to the COVID-19 outbreak, it is expected that there will be more demand for new drugs, which is likely to push the demand for APIs and consequently increase ‘affect the global active pharmaceutical market in the world.

Biopharmaceutical companies opt for mergers and acquisitions to access new technologies, expand their market and increase their capital for clinical trials and investments. The API market has experienced impressive growth in recent years. This growth trend is expected to continue due to increased demand from Asia Pacific region in the future. This is mainly motivated by China, India and Japan which consist of a huge population and therefore a huge incidence of infectious diseases requiring drugs for treatment.

The rising death toll and the spread of the virus has prompted many pharmaceutical companies, biopharmaceutical companies and small startups to collaborate and come up with effective drugs to fight the same. Scientists around the world have found molecules that can effectively target COVID-19. Currently, 155 molecules are under clinical investigation and 45 molecules are in preclinical development to be targeted against COVID-19. Locally monitored businesses to protect the safety of study participants, staff and employees during these times.

Report scope

  • The report presents the Active Pharmaceutical Ingredients market analysis for the historical period 2016-2020 and the forecast period 2021-2026.

  • The report analyzes the active pharmaceutical ingredients market by value (USD billion)

  • The report analyzes the Active Pharmaceutical Ingredients Market by Application (Oncology, Cardiology, Diabetes, Neurology and Others)

  • The report analyzes the Active Pharmaceutical Ingredients Market by Drug Type (Generic API and Innovative API)

  • The report analyzes the Active Pharmaceutical Ingredients Market by Synthesis (synthetic and biotech)

  • The Global Active Pharmaceutical Ingredients Market has been analyzed by region (North America, Europe, Asia Pacific and LAMEA)

  • The Global Active Pharmaceutical Ingredients Market has been analyzed by country (United States, Canada, Germany, France, UK, Italy, Spain, China, Japan and India)

  • The attractiveness of the market has been presented by region, by application, by drug type and by synthesis.

  • Also, major industry opportunities, trends, drivers, and challenges have been analyzed in the report.

  • The report tracks competitive developments, strategies, mergers and acquisitions, and new product development. Companies analyzed in the report include Pfizer Inc., GlaxoSmithKline, AbbVie Inc., Novartis AG, Eli Lilly and Company, Merck KGaA, Teva Pharmaceutical Industries Ltd., Sanofi, Bristol-Myers Squibb and Boehringer Ingelheim.

Main topics covered:

1. Report Scope and Methodology

2. Strategic Recommendations

3. Active Pharmaceutical Ingredients Market: Product Outlook

4. Global Active Pharmaceutical Ingredients Market: Size and Forecast
4.1 Global Active Pharmaceutical Ingredients Market Size, by Value, Year 2016- 2026

5. Global Active Pharmaceutical Ingredients Market Segmentation- By Application, By Drug Type, By Synthesis
5.1 Global Active Pharmaceutical Ingredients Market Competitive Scenario: By Application
5.1.1 Oncology – Market Size and Forecast (2016-2026)
5.1.2 Cardiology – Market Size and Forecast (2016-2026)
5.1.3 Diabetes – Market Size and Forecast (2016-2026)
5.1.4 Neurology – Market Size and Forecast (2016-2026)
5.1.5 Others – Market Size and Forecast (2016-2026)
5.2 Global Active Pharmaceutical Ingredients Market Competitive Scenario: By Drug Type
5.2.1 Generic API – Market Size and Forecast (2016-2026)
5.2.2 Innovative API – Market Size and Forecast (2016-2026)
5.3 Global Active Pharmaceutical Ingredients Market Competitive Scenario: By Synthesis
5.3.1 Synthetics – Market Size and Forecast (2016-2026)
5.3.2 Biotechnology – Market Size and Forecast (2016-2026)

6. Global Active Pharmaceutical Ingredients Market: Regional Analysis
6.1 Global Active Pharmaceutical Ingredients Market Competitive Scenario: By Region

7. North America Active Pharmaceutical Ingredients Market: An Analysis (2016-2026)

8. Europe Active Pharmaceutical Ingredients Market: Segmentation: An Analysis (2016-2026)

9. Asia-Pacific Active Pharmaceutical Ingredients Market: An Analysis (2016-2026)

10. Global Active Pharmaceutical Ingredients Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Trends

11. Market attractiveness
11.1 Market Attractiveness Chart of Global Active Pharmaceutical Ingredients Market – By Application, 2026
11.2 Market Attractiveness Chart of Global Active Pharmaceutical Ingredients Market – By Drug Type, 2026
11.3 Market Attractiveness Chart of Global Active Pharmaceutical Ingredients Market – By Synthesis, 2026
11.4 Market Attractiveness Chart of Global Active Pharmaceutical Ingredients Market – By Region, 2026

12. Competitive landscape
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
12.2 Market Share Analysis

13. Business Profiles
13.1 Pfizer Inc.,
13.2 GlaxoSmithKline
13.3 AbbVie Inc.
13.4 Novartis AG
13.5 Eli Lilly and company
13.6 Merck KGaA
13.7 Teva Pharmaceutical Industries Ltd.
13.8 Sanofi
13.9 Bristol-Myers Squibb
13.10 Boehringer Ingelheim

For more information about this report visit https://www.researchandmarkets.com/r/z0fvo8

Media Contact:

Research and Markets
Laura Wood, senior
[email protected]

For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900

US Fax: 646-607-1904
Fax (outside the US): +353-1-481-1716

Quote

Quote

View original content: https://www.prnewswire.com/news-releases/insights-on-the-active-pharmaceutical-ingredient-global-market-to-2026—key-drivers-restraints-and-trends – 301464908.html

SOURCE Research and Markets

Share.

Comments are closed.